Study finds loss of RBFOX2 protein promotes pancreatic cancer metastasis through effects on cytoskeletal remodeling

Pancreatic cancer presents a challenging prognosis, marked by a five-year overall survival rate of merely 12.5%. Diagnosis frequently occurs at an advanced stage, characterized by metastasis to distant sites. The intricate molecular mechanisms governing pancreatic cancer metastasis remain a subject of ongoing research and exploration.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart